BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 19268008)

  • 1. 5-aminolevulinate synthase: catalysis of the first step of heme biosynthesis.
    Hunter GA; Ferreira GC
    Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):102-10. PubMed ID: 19268008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of 5-aminolevulinate synthase and the role of the protein environment in controlling the cofactor chemistry.
    Ferreira GC; Zhang JS
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):827-33. PubMed ID: 12699240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of 5-aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans.
    Astner I; Schulze JO; van den Heuvel J; Jahn D; Schubert WD; Heinz DW
    EMBO J; 2005 Sep; 24(18):3166-77. PubMed ID: 16121195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aminolevulinate synthase and the first step of heme biosynthesis.
    Ferreira GC; Gong J
    J Bioenerg Biomembr; 1995 Apr; 27(2):151-9. PubMed ID: 7592562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular permutation of 5-aminolevulinate synthase as a tool to evaluate folding, structure and function.
    Ferreira GC; Cheltsov AV
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):11-6. PubMed ID: 11929042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias.
    Peoc'h K; Nicolas G; Schmitt C; Mirmiran A; Daher R; Lefebvre T; Gouya L; Karim Z; Puy H
    Mol Genet Metab; 2019 Nov; 128(3):190-197. PubMed ID: 30737140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asn-150 of Murine Erythroid 5-Aminolevulinate Synthase Modulates the Catalytic Balance between the Rates of the Reversible Reaction.
    Stojanovski BM; Ferreira GC
    J Biol Chem; 2015 Dec; 290(52):30750-61. PubMed ID: 26511319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysine-313 of 5-aminolevulinate synthase acts as a general base during formation of the quinonoid reaction intermediates.
    Hunter GA; Ferreira GC
    Biochemistry; 1999 Mar; 38(12):3711-8. PubMed ID: 10090759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythroid 5-aminolevulinate synthase and X-linked sideroblastic anemia.
    Ferreira GC
    J Fla Med Assoc; 1993 Jul; 80(7):481-3. PubMed ID: 8089650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular enzymology of 5-aminolevulinate synthase, the gatekeeper of heme biosynthesis.
    Hunter GA; Ferreira GC
    Biochim Biophys Acta; 2011 Nov; 1814(11):1467-73. PubMed ID: 21215825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for dysregulation of aminolevulinic acid synthase in human disease.
    Taylor JL; Brown BL
    J Biol Chem; 2022 Mar; 298(3):101643. PubMed ID: 35093382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Correlation between the Dynamics of the Active Site Loop and C-Terminal Tail in Relation to the Homodimer Asymmetry of the Mouse Erythroid 5-Aminolevulinate Synthase.
    Na I; Catena D; Kong MJ; Ferreira GC; Uversky VN
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29958424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unstable reaction intermediates and hysteresis during the catalytic cycle of 5-aminolevulinate synthase: implications from using pseudo and alternate substrates and a promiscuous enzyme variant.
    Stojanovski BM; Hunter GA; Jahn M; Jahn D; Ferreira GC
    J Biol Chem; 2014 Aug; 289(33):22915-22925. PubMed ID: 24920668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the β-subunit of succinyl-CoA synthetase (SUCLA2).
    Bishop DF; Tchaikovskii V; Hoffbrand AV; Fraser ME; Margolis S
    J Biol Chem; 2012 Aug; 287(34):28943-55. PubMed ID: 22740690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspartate-279 in aminolevulinate synthase affects enzyme catalysis through enhancing the function of the pyridoxal 5'-phosphate cofactor.
    Gong J; Hunter GA; Ferreira GC
    Biochemistry; 1998 Mar; 37(10):3509-17. PubMed ID: 9521672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient state kinetic investigation of 5-aminolevulinate synthase reaction mechanism.
    Zhang J; Ferreira GC
    J Biol Chem; 2002 Nov; 277(47):44660-9. PubMed ID: 12191993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia.
    Fujiwara T; Okamoto K; Niikuni R; Takahashi K; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Nakamura Y; Nakajima M; Tanaka T; Harigae H
    Biochem Biophys Res Commun; 2014 Nov; 454(1):102-8. PubMed ID: 25450364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Aminolevulinate synthase catalysis: The catcher in heme biosynthesis.
    Stojanovski BM; Hunter GA; Na I; Uversky VN; Jiang RHY; Ferreira GC
    Mol Genet Metab; 2019 Nov; 128(3):178-189. PubMed ID: 31345668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine erythroid 5-aminolevulinate synthase: Truncation of a disordered N-terminal extension is not detrimental for catalysis.
    Stojanovski BM; Breydo L; Uversky VN; Ferreira GC
    Biochim Biophys Acta; 2016 May; 1864(5):441-52. PubMed ID: 26854603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLRX5 mutations impair heme biosynthetic enzymes ALA synthase 2 and ferrochelatase in Human congenital sideroblastic anemia.
    Daher R; Mansouri A; Martelli A; Bayart S; Manceau H; Callebaut I; Moulouel B; Gouya L; Puy H; Kannengiesser C; Karim Z
    Mol Genet Metab; 2019 Nov; 128(3):342-351. PubMed ID: 30660387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.